Principal Investigator
Matthew Schlumbrecht
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240947
Clinical Trial Summary
An Open-Label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647